Month: July 2023

PRDX6 Protein: A Shield Against Oxidative Damage in RPE Cells

The retinal pigment epithelium (RPE) cells are like guardians of the eye, protecting it from oxidative stress that can lead to vision-damaging diseases. However, the exact mechanisms behind this protection have been a mystery. In this study, researchers explored how hydrogen peroxide (H2O2) damages RPE cells and the role of peroxiredoxin 6 (PRDX6) protein in […]

Published on July 17, 2023

Unleashing the Power of Exercise for Parkinson’s Disease Patients

Just like different exercises have different effects on our bodies, they also have different effects on Parkinson’s disease patients! Researchers conducted a systematic review and network meta-analysis to determine which types of exercises are most effective in improving postural balance in Parkinson’s disease patients. They gathered data from a total of 60 randomized controlled trials, […]

Published on July 17, 2023

Acumen’s Alzheimer’s Drug Passes Initial Safety Test

A groundbreaking Alzheimer’s drug, developed by Acumen Pharmaceuticals and aimed at combating the toxic protein beta amyloid in the brain, has successfully passed its initial safety test and is set to proceed to a larger trial phase. Known as ACI193, this innovative drug demonstrated excellent tolerance during the preliminary studies… An experimental Alzheimer’s disease drug […]

Published on July 17, 2023